Literature DB >> 33559808

Better pain control with 8-gray single fraction palliative radiotherapy for skeletal metastases: a Bayesian network meta-analysis.

Filippo Migliorini1, Jörg Eschweiler2, Andromahi Trivellas3, Arne Driessen2, Matthias Knobe4, Markus Tingart2, Nicola Maffulli5,6,7.   

Abstract

External Beam Radiotherapy (EBRT) allows remarkable pain control in patients with skeletal metastases. We performed a Bayesian network meta-analysis comparing the most commonly used radiotherapy regimens for palliative management in patients with skeletal metastases. The main online databases were accessed in October 2020. All randomized clinical trials evaluating the irradiation of painful bone metastases were considered. The following irradiation patterns were analysed and included in the present network meta-analysis: 8 Gy- and 10 Gy/single fraction, 20 Gy/5 fractions, 30 Gy/10 fractions. The Bayesian hierarchical random-effect model analysis was adopted in all comparisons. The Log Odds-Ratio (LOR) statistical method for dichotomic data was adopted for analysis. Data from 3595 patients were analysed. The mean follow-up was 9.5 (1 to 28) months. The cumulative mean age was 63.3 ± 2.9. 40.61% (1461 of 3595 patients) were female. The 8Gy/single fraction protocol detected reduced rate of "no pain response" (LOR 3.39), greater rate of "pain response" (LOR-5.88) and complete pain remission (LOR-7.05) compared to the other dose patterns. The 8Gy group detected a lower rate of pathological fractures (LOR 1.16), spinal cord compression (LOR 1.31) and re-irradiation (LOR 2.97) compared to the other dose patterns. Palliative 8Gy/single fraction radiotherapy for skeletal metastases shows outstanding results in terms of pain control, re-irradiations, pathological fractures and spinal cord compression, with no differences in terms of survivorship compared to the other multiple dose patterns.Level of evidence: I, Bayesian network meta-analysis of RCTs.

Entities:  

Keywords:  Bone metastases; Fracture; Pain; Radiotherapy; Survivorship

Year:  2021        PMID: 33559808      PMCID: PMC7987640          DOI: 10.1007/s10585-020-10067-7

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  56 in total

Review 1.  Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.

Authors:  Stephen Lutz; Lawrence Berk; Eric Chang; Edward Chow; Carol Hahn; Peter Hoskin; David Howell; Andre Konski; Lisa Kachnic; Simon Lo; Arjun Sahgal; Larry Silverman; Charles von Gunten; Ehud Mendel; Andrew Vassil; Deborah Watkins Bruner; William Hartsell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-27       Impact factor: 7.038

2.  Multifactorial index of cardiac risk in noncardiac surgical procedures.

Authors:  L Goldman; D L Caldera; S R Nussbaum; F S Southwick; D Krogstad; B Murray; D S Burke; T A O'Malley; A H Goroll; C H Caplan; J Nolan; B Carabello; E E Slater
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

Review 3.  Cancer and bone.

Authors:  T A Guise; G R Mundy
Journal:  Endocr Rev       Date:  1998-02       Impact factor: 19.871

Review 4.  Metastatic bone disease: clinical features, pathophysiology and treatment strategies.

Authors:  R E Coleman
Journal:  Cancer Treat Rev       Date:  2001-06       Impact factor: 12.111

5.  Radiation therapy for the management of painful bone metastases: Results from a randomized trial.

Authors:  Lucia Gutiérrez Bayard; María Del Carmen Salas Buzón; Esther Angulo Paín; Lourdes de Ingunza Barón
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-06

6.  [Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study].

Authors:  S Koswig; V Budach
Journal:  Strahlenther Onkol       Date:  1999-10       Impact factor: 3.621

7.  Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.

Authors:  Trevor Powles; Sandy Paterson; John A Kanis; Eugene McCloskey; Sue Ashley; Alwynne Tidy; Kirsi Rosenqvist; Ian Smith; Lars Ottestad; Sandra Legault; Marjo Pajunen; Auli Nevantaus; Esa Männistö; Anne Suovuori; Sari Atula; Jaakko Nevalainen; Liisa Pylkkänen
Journal:  J Clin Oncol       Date:  2002-08-01       Impact factor: 44.544

Review 8.  Bone metastases: a comprehensive review of the literature.

Authors:  Filippo Migliorini; Nicola Maffulli; Andromahi Trivellas; Jörg Eschweiler; Markus Tingart; Arne Driessen
Journal:  Mol Biol Rep       Date:  2020-08-04       Impact factor: 2.316

9.  International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?

Authors:  Alysa Fairchild; Elizabeth Barnes; Sunita Ghosh; Edgar Ben-Josef; Daniel Roos; William Hartsell; Tanya Holt; Jackson Wu; Nora Janjan; Edward Chow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-21       Impact factor: 7.038

10.  The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.

Authors:  Brian Hutton; Georgia Salanti; Deborah M Caldwell; Anna Chaimani; Christopher H Schmid; Chris Cameron; John P A Ioannidis; Sharon Straus; Kristian Thorlund; Jeroen P Jansen; Cynthia Mulrow; Ferrán Catalá-López; Peter C Gøtzsche; Kay Dickersin; Isabelle Boutron; Douglas G Altman; David Moher
Journal:  Ann Intern Med       Date:  2015-06-02       Impact factor: 25.391

View more
  1 in total

1.  Surgical outcomes and risk factors for poor outcomes in patients with cervical spine metastasis: a prospective study.

Authors:  Yutaro Kanda; Kenichiro Kakutani; Yoshitada Sakai; Zhongying Zhang; Takashi Yurube; Shingo Miyazaki; Yuji Kakiuchi; Yoshiki Takeoka; Ryu Tsujimoto; Kunihiko Miyazaki; Hiroki Ohnishi; Yuichi Hoshino; Toru Takada; Ryosuke Kuroda
Journal:  J Orthop Surg Res       Date:  2021-07-03       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.